MeiraGTx
MGTX
#6681
Rank
C$0.89 B
Marketcap
C$11.11
Share price
-1.94%
Change (1 day)
63.07%
Change (1 year)

Revenue for MeiraGTx (MGTX)

Revenue in 2025 (TTM): C$48.6 Million

According to MeiraGTx's latest financial reports the company's current revenue (TTM ) is C$47.51 Million. In 2024 the company made a revenue of C$47.75 Million an increase over the revenue in the year 2023 that were of C$18.59 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for MeiraGTx from 2017 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) C$48.6 M1.79%
2024 C$47.75 M156.86%
2023 C$18.59 M-13.94%
2022 C$21.6 M-55.04%
2021 C$48.04 M142.12%
2020 C$19.84 M14.31%
2019 C$17.36 M
2018 N/A
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novocure
NVCR
C$0.85 B 1,701.64% Jersey
Novavax
NVAX
C$1.67 B 3,419.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Organovo
ONVO
C$0.19 M-99.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
C$30.06 M-36.71%๐Ÿ‡ฌ๐Ÿ‡ง UK